National
Healius deal is the right prescription – The Australian Financial Review
By selling its medical centres business, Healius becomes a simpler, stronger business – and one better placed to extract value from its private equity suitor.
Way back on February 25 eons ago in these COVID-19 times Partners Group lobbed a $3.40 a share bid at Healius, after striking a deal to gain the support of the healthcare groups major shareholder, Ch…
Continue Reading